Acta Microbiologica et Immunologica Hungarica
Volume/Issue:
Volume 71: Issue 3
16S rRNA based metagenomic analysis unveils unique oral microbial signatures in oral squamous cell carcinoma cases from Coastal Karnataka, India
Authors:
KG Aparna Nitte (Deemed to be University), Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education and Research (NUCSER), Deralakatte, Mangaluru-575018, India

Search for other papers by KG Aparna in
Current site
Google Scholar
PubMed Close
,
Jeshma Ravindra Nitte (Deemed to be University), Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education and Research (NUCSER), Deralakatte, Mangaluru-575018, India

Search for other papers by Jeshma Ravindra in
Current site
Google Scholar
PubMed Close
,
Gunimala Chakraborty Nitte (Deemed to be University), Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education and Research (NUCSER), Deralakatte, Mangaluru-575018, India

Search for other papers by Gunimala Chakraborty in
Current site
Google Scholar
PubMed Close
,
Krishna Kumar Ballamoole Nitte (Deemed to be University), Department of Infectious Diseases and Microbial Genomics, Nitte University Centre for Science Education and Research, Deralakatte, Mangaluru-575018, India

Search for other papers by Krishna Kumar Ballamoole in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0001-7821-7419
,
JR Vinaya Kumar Nitte (Deemed to be University), Department of Surgical Oncology, Justice K.S Hegde Charitable Hospital, Deralakatte, Mangaluru-575018, India

Search for other papers by JR Vinaya Kumar in
Current site
Google Scholar
PubMed Close
, and
Anirban Chakraborty Nitte (Deemed to be University), Department of Molecular Genetics and Cancer, Nitte University Centre for Science Education and Research (NUCSER), Deralakatte, Mangaluru-575018, India

Search for other papers by Anirban Chakraborty in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0003-3476-6576
Pages:
253–262
Online Publication Date:
01 Jul 2024
Publication Date:
18 Sep 2024
Article Category:
Research Article
DOI:
https://doi.org/10.1556/030.2024.02307
Keywords:
oral squamous cell carcinoma (OSCC); oral microbiota; dysbiosis; 16S rRNA-based metagenomics
Restricted access

Abstract

Oral Squamous cell carcinoma (OSCC) is the 14th most frequent cancer with 300,000 new cases and 100,000 deaths reported annually. Even with advanced therapy, the treatment outcomes are poor at advanced stages of the disease. The diagnosis of early OSCC is of paramount clinical value given the high mortality rate associated with the late stages of the disease. Recently, the role of microbiome in the disease manifestation, including oral cancer, has garnered considerable attention. But, to establish the role of bacteria in oral cancer, it is important to determine the differences in the colonization pattern in non-tumour and tumour tissues. In this study, 16S rRNA based metagenomic analyses of 13 tumorous and contralateral anatomically matched normal tissue biopsies, obtained from patients with advanced stage of OSCC were evaluated to understand the correlation between OSCC and oral microbiome. In this study we identified Fusobacterium, Prevotella, Capnocytophaga, Leptotrichia, Peptostreptococcus, Parvimonas and Bacteroidetes as the most significantly enriched taxa in OSCC lesions compared to the non-cancerous tissues. Further, PICRUSt2 analysis unveiled enhanced expression of metabolic pathways associated with L-lysine fermentation, pyruvate fermentation, and isoleucine biosynthesis in those microbes associated with OSCC tissues. These findings provide valuable insights into the distinctive microbial signatures associated with OSCC, offering potential biomarkers and metabolic pathways underlying OSCC pathogenesis. While our focus has primarily centred on microbial signatures, it is essential to recognize the pivotal role of host factors such as immune responses, genetic predisposition, and the oral microenvironment in shaping OSCC development and microbiome composition.

  • 1.

    Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer [Internet]. 2015 Mar [cited 2024 Jun 10]; 136(5). Available from: https://onlinelibrary.wiley.com/doi/10.1002/ijc.29210.

    • Search Google Scholar
    • Export Citation
  • 2.

    Tandon P, Dadhich A, Saluja H, Bawane S, Sachdeva S. The prevalence of squamous cell carcinoma in different sites of oral cavity at our Rural Health Care Centre in Loni, Maharashtra – a retrospective 10-year study. Współczesna Onkol 2017; 2: 178–83.

    • Search Google Scholar
    • Export Citation
  • 3.

    Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. The Lancet 2006 May; 367(9524): 1747–57.

    • Search Google Scholar
    • Export Citation
  • 4.

    Peng X, Cheng L, You Y, Tang C, Ren B, Li Y, et al. Oral microbiota in human systematic diseases. Int J Oral Sci 2022 Dec; 14(1): 14.

  • 5.

    Zini A, Czerninski R, Sgan‐Cohen HD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med 2010 Apr; 39(4): 299–305.

    • Search Google Scholar
    • Export Citation
  • 6.

    Vimal J, Himal I, Kannan S. Role of microbial dysbiosis in carcinogenesis & cancer therapies. Indian J Med Res 2020 Dec; 152(6): 553–61.

    • Search Google Scholar
    • Export Citation
  • 7.

    Speight PM, Farthing PM. The pathology of oral cancer. Br Dent J 2018 Nov; 225(9): 841–7.

  • 8.

    Lin YW, Kang WP, Huang BL, Qiu ZH, Wei LF, Zhang B, et al. Nomogram based on clinical characteristics and serological inflammation markers to predict overall survival of oral tongue squamous cell carcinoma patient after surgery. BMC Oral Health 2021 Dec; 21(1): 667.

    • Search Google Scholar
    • Export Citation
  • 9.

    Du Q, Fu M, Zhou Y, Cao Y, Guo T, Zhou Z, et al. Sucrose promotes caries progression by disrupting the microecological balance in oral biofilms: an in vitro study. Sci Rep 2020 Feb 19; 10(1): 2961.

    • Search Google Scholar
    • Export Citation
  • 10.

    Verma D, Garg PK, Dubey AK. Insights into the human oral microbiome. Arch Microbiol 2018 May; 200(4): 525–40.

  • 11.

    Rusthen S, Kristoffersen AK, Young A, Galtung HK, Petrovski BÉ, Palm Ø, et al. Dysbiotic salivary microbiota in dry mouth and primary Sjögren’s syndrome patients. Appel S, editor. Plos One. 2019 Jun 18; 14(6): e0218319.

    • Search Google Scholar
    • Export Citation
  • 12.

    Arthur JC, Perez-Chanona E, Mühlbauer M, Tomkovich S, Uronis JM, Fan TJ, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012 Oct 5; 338(6103): 120–3.

    • Search Google Scholar
    • Export Citation
  • 13.

    Dekaboruah E, Suryavanshi MV, Chettri D, Verma AK. Human microbiome: an academic update on human body site specific surveillance and its possible role. Arch Microbiol 2020 Oct; 202(8): 2147–67.

    • Search Google Scholar
    • Export Citation
  • 14.

    Loesche W. Dental caries and periodontitis: contrasting two infections that have medical implications. Infect Dis Clin North Am 2007 Jun; 21(2): 471–502.

    • Search Google Scholar
    • Export Citation
  • 15.

    Fejerskov O. Changing paradigms in concepts on dental caries: consequences for oral health care. Caries Res 2004; 38(3): 182–91.

  • 16.

    Mazzio EA, Smith B, Soliman KFA. Evaluation of endogenous acidic metabolic products associated with carbohydrate metabolism in tumor cells. Cell Biol Toxicol 2010 Jun; 26(3): 177–88.

    • Search Google Scholar
    • Export Citation
  • 17.

    Moritani K, Takeshita T, Shibata Y, Ninomiya T, Kiyohara Y, Yamashita Y. Acetaldehyde production by major oral microbes. Oral Dis 2015 Sep; 21(6): 748–54.

    • Search Google Scholar
    • Export Citation
  • 18.

    Irfan M, Delgado RZR, Frias-Lopez J. The oral microbiome and cancer. Front Immunol 2020 Oct 23; 11: 591088.

  • 19.

    Rai AK, Panda M, Das AK, Rahman T, Das R, Das K, et al. Dysbiosis of salivary microbiome and cytokines influence oral squamous cell carcinoma through inflammation. Arch Microbiol 2021 Jan; 203(1): 137–52.

    • Search Google Scholar
    • Export Citation
  • 20.

    Caspi R, Billington R, Fulcher CA, Keseler IM, Kothari A, Krummenacker M, et al. The MetaCyc database of metabolic pathways and enzymes. Nucleic Acids Res 2018 Jan 4; 46(D1): D633–9.

    • Search Google Scholar
    • Export Citation
  • 21.

    Guduguntla P, Guttikonda VR. Estimation of serum pyruvic acid levels in oral squamous cell carcinoma. J Oral Maxillofac Pathol JOMFP 2020; 24(3): 585.

    • Search Google Scholar
    • Export Citation
  • 22.

    Enomoto Y, Kimoto A, Suzuki H, Nishiumi S, Yoshida M, Komori T. Exploring a novel screening method for patients with oral squamous cell carcinoma: a plasma metabolomics analysis. Kobe J Med Sci 2018 Sep 11; 64(1): E26–35.

    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand
Cover Acta Microbiologica et Immunologica Hungarica
Acta Microbiologica et Immunologica Hungarica A Quarterly of the Hungarian Academy of Sciences
Print ISSN:
1217-8950
Online ISSN:
1588-2640

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • CABELLS Journalytics
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded

2023  
Web of Science  
Journal Impact Factor 1.3
Rank by Impact Factor Q4 (Immunology)
Journal Citation Indicator 0.31
Scopus  
CiteScore 2.3
CiteScore rank Q3 (Infectious Diseases)
SNIP 0.389
Scimago  
SJR index 0.308
SJR Q rank Q3

Acta Microbiologica et Immunologica Hungarica
Publication Model Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article (only for OA publications)
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2025 Online subsscription: 772 EUR / 848 USD
Print + online subscription: 860 EUR / 944 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation		 1954
Volumes
per Year		 1
Issues
per Year		 4
Founder Magyar Tudományos Akadémia
Founder's
Address		 H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jun 2024 0 0 0
Jul 2024 1932 12 18
Aug 2024 219 2 4
Sep 2024 219 5 7
Oct 2024 420 3 4
Nov 2024 292 2 3
Dec 2024 54 0 0